FDA
-
-
-
-
-
-
-
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
-
-
-
-
-
-
-
Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
-
-
-
-
-
-
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
-
-
-
-
-
-
-
Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer
-
-
-
-
-
-
-
Immunome Inc. (IMNM) To Acquire AL102
-
-
-
-
-
-
-
Immunome (IMNM) Publishes Preclinical Research Demonstrating that Inhibition of IL-38
-
-
-
-
-
-
-
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
-
329,909 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

